You are here: Home » International » News » Politics
Business Standard

US President Biden hopes to send AstraZeneca vaccine to countries by July 4

President Joe Biden provided an update on White House on goals for providing AstraZeneca Covid-19 vaccines to countries by July 4

Joe Biden | AstraZeneca | Coronavirus Tests

ANI  |  US 

joe biden


Washington [US], May 5 (ANI): President on Tuesday (local time) provided an update from the White House on goals for providing AstraZeneca's COVID-19 vaccine to countries by July 4.

"I am not prepared to announce who else we will be giving the vaccine to, but we are going to by the Fourth of July have spent about 10 per cent of what we have to other nations including some of the ones who you mentioned," said Biden while responding to a question about when vaccines will be provided to countries like India and Brazil.

"We're helping Brazil and India, significantly. I spoke to Prime Minister Modi. What he needs most is the material and the parts to be able to have his machines that can make the vaccine work, we're sending oxygen. We're sending them a lot of the precursors. So, we're doing a lot for India," he said.

The US will be sending 60 million doses of the vaccine to other countries starting from June 2021, the White House announced earlier.

"That means of all the vaccines we produced for the United States at that time, we will have given about 10 per cent to the rest of the world as a significant humanitarian commitment in addition to our funding of COVAX," said Biden.

On Tuesday, Biden announced a plan of ensuring 70 per cent of American adults receive at least one dose of the coronavirus vaccine by Independence Day.

"Our goal by July 4 is to have 70 per cent of adult Americans with at least one shot and 160 million Americans fully vaccinated," Biden said at the White House on Tuesday.

"That means giving close to 100m shots - some first shots, others second shots - over the next 60 days."

At the briefing, President Biden said that he has not yet announced whether his administration will support a global push to waive intellectual property protections on COVID-19 vaccines.

"We're going to decide that as we go along," he told reporters following a White House briefing on vaccine distribution. "I haven't made that decision yet."

The Biden administration is facing pressure from the community, drug pricing advocates and congressional Democrats to back a move that would temporarily waive the Trade-Related Aspects of Intellectual Property Rights agreement (TRIPS), that protects pharmaceutical trade secrets.

The World Trade Organization will assess the waiver, which has effectively provided pharmaceutical companies monopoly over vaccine production, potentially locking out poor countries from expanding their supplies. The Biden administration is expected to set its position clearly at the World Trade Organization meeting on Wednesday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, May 05 2021. 06:33 IST